Search clinical trials for: Anti-Obesity Agents

Total 189151 results

University of California, Davis
U.S. Army Medical Research and Development Command

Completed

Metabolism of the Insecticide Permethrin

Pharmacokinetics | Metabolism

United States
AstraZeneca

Completed

Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus

Diabetes Mellitus

United States, Hungary, Slovakia, South Africa, Poland, Romania
AstraZeneca
Eli Lilly and Company

Completed

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

Obesity

United States, Puerto Rico
Radboud University Medical Center
AstraZeneca

Completed

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Hypoglycemia | Diabetes Mellitus, Type 1

Netherlands
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
DoCare Pharmaceutial Technology Co.,Ltd

Recruiting

Efficacy and Safety of Zihua Wenfei Granules in Treatment of Postinfectious Cough (Wind-cold Invading Lungs Syndrome)

Cough

China
University of California, San Diego

Completed

Parents as the Agent of Change for Childhood Obesity (PAAC)

Obesity

United States
Tim Van den Wyngaert
Kom Op Tegen Kanker

Recruiting

Best Treatment Choice for Osteonecrosis of the Jaw (BETCON)

Medication Related Osteonecrosis of the Jaw

Belgium
Emory University
National Institute of Environmental Health Sciences (NIEHS); Healthway Compounding... and other collaborators

Completed

Weight Loss Aid in an Exposed Population

Polybrominated Biphenyl Poisoning

United States
Neuroscience Trials Australia
National Health and Medical Research Council, Australia; Monash University

Active, not recruiting

Trial of EXenatide in Acute Ischaemic Stroke (TEXAIS)

Acute Ischemic Stroke

Australia, Finland, New Zealand
Nanfang Hospital of Southern Medical University

Completed

Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy

Diabetic Nephropathies
Montefiore Medical Center
National Institutes of Health (NIH)

Completed

Role of Exenatide in Type 1 Diabetes

Type 1 Diabetes

United States
The University of Texas Health Science Center at...
Amylin Pharmaceuticals, LLC.

Completed

Acute Effect of Exenatide on Brain Glucose Metabolism

Diabetes | Impaired Glucose Tolerance (IGT)

United States
University of Michigan
Eli Lilly and Company; Amylin Pharmaceuticals, LLC.

Completed

Evaluation of Exenatide in Patients With Diabetic Neuropathy

Type 2 Diabetes Mellitus | Diabetic Peripheral Neuropathy

United States
Ingrid Jazet
AstraZeneca

Unknown

Exenatide and Brown Adipose Tissue (exe01)

Obesity

Netherlands
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin

Type 2 Diabetes Mellitus

Korea, Republic of, China, Taiwan, India
University of Aarhus
Eli Lilly and Company; Aarhus University Hospital

Completed

The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET

Type 2 Diabetes

Denmark
Advanced Specialty Care

Unknown

The Effects of Exenatide After Gastric Restriction (AGREE)

Morbid Obesity

United States
The First Hospital of Jilin University

Unknown

A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Diabetes Mellitus, Type 2

China
Holbaek Sygehus
University of Copenhagen; Herlev Hospital; The Novo Nordisk Foundation Center... and other collaborators

Completed

Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight

Hypertension | Childhood Obesity | Hyperlipidemia | Insulin Sensitivity | NAFLD (Non-alcoholic Fatty Liver Disease)

Denmark
Mansoura University

Completed

Central Obesity in Cases of OAB

Urologic Diseases | Obesity, Abdominal | Overactive Bladder Syndrome
Eskisehir Osmangazi University

Unknown

Evaluation of the Effectiveness of Internet Based Nutrition and Physical Activity Education Programme in Adolescents

Obesity

Turkey
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparison of Workplace Obesity Management Programs

Heart Diseases | Cardiovascular Diseases | Obesity
Radboud University Medical Center

Recruiting

BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation (BetaFIT)

Type 1 Diabetes

Netherlands
General Committee of Teaching Hospitals and Institutes...

Not yet recruiting

Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.

Morbid Obesity

Egypt
Yale University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility (FIT-PLESE)

Infertility, Female

United States
University College, London

Unknown

Exenatide Once-weekly as a Treatment for Multiple System Atrophy (MSA)

Multiple System Atrophy

United Kingdom
Yale University
Donaghue Medical Research Foundation

Completed

Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

Obesity | Binge Eating

United States
Beth Israel Deaconess Medical Center
Eli Lilly and Company; Amylin Pharmaceuticals, LLC.

Completed

The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women

Obesity | Impaired Glucose Tolerance

United States
Intarcia Therapeutics

Completed

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

Type 2 Diabetes

Finland, United States, Bulgaria, Poland, South Africa, Denmark, Turkey, Slovakia, Germany
Intarcia Therapeutics

Completed

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes

Type 2 Diabetes

United States
AstraZeneca
Eli Lilly and Company

Completed

Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Italy
AstraZeneca
Eli Lilly and Company

Completed

Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)

Type 2 Diabetes

Japan
AstraZeneca
Eli Lilly and Company

Completed

A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes

Type 2 Diabetes

Japan
AstraZeneca
Eli Lilly and Company

Completed

Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination

Diabetes Mellitus, Type 2

Hungary
US Department of Veterans Affairs

Completed

A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

Obesity | Diabetes Mellitus

United States
Dong-A Pharmaceutical Co., Ltd.

Completed

Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects (SR-Exenatide)

Diabetes Mellitus

Korea, Republic of
Peptron, Inc.

Completed

A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide

Type 2 Diabetes Mellitus

Korea, Republic of
Société des Produits Nestlé (SPN)

Completed

Comparison of MAG and Fish Oil Efficacy

Obesity

Switzerland
Carl T. Hayden VA Medical Center

Completed

Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation

Type 2 Diabetes Mellitus | Impaired Glucose Tolerance

United States
Tianjin Medical University

Recruiting

A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease

Vogt-Koyanagi-Harada Disease | Mycophenolate Mofetil

China
RenJi Hospital

Completed

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

Polycystic Ovary Syndrome | Overweight and Obesity | Disorder of Glucose Regulation

China
Novo Nordisk A/S

Completed

Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes (LEAD-6)

Diabetes Mellitus, Type 2 | Diabetes

United States, Poland, Puerto Rico, Denmark, Sweden, Austria, Germany, Macedonia, The Former Yugoslav Republic of, Slovenia, France, Switzerland, Norway, Spain, Ireland, Finland, Romania
University Hospital, Caen
Eli Lilly and Company

Unknown

Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes (EXEPUMP)

Type 2 Diabetes

France
AstraZeneca
Eli Lilly and Company

Completed

Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
Mayo Clinic

Withdrawn

Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome

Short Bowel Syndrome
Bispebjerg Hospital
Rigshospitalet, Denmark

Recruiting

STRONG for Surgery & Strong for Life - Against All Odds: Intensive Prehabilitation for Risk Reduction in Cancer Surgery (STRONG-CS)

Surgery | Risk Reduction | Life Style | Urological Cancer

Denmark
Seattle Children's Hospital
Vanderbilt University; Children's Hospitals and Clinics of Minnesota

Completed

Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity (ECHO)

Hypothalamic Obesity

United States
Gachon University Gil Medical Center

Completed

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

Obesity

Korea, Republic of

Search clinical trials for: Anti-Obesity Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations